β-Cyclodextrin-based ternary complexes of haloperidol and organic acids: the effect of organic acids on the drug solubility enhancement

Abstract Haloperidol (HALO) is a weak base with very low aqueous solubility that is used as an antipsychotic drug. This study aimed to improve its solubility by forming HALO/β-cyclodextrin (β-CD)-based ternary complexes with organic acids. The solubility of HALO/β-CD binary and HALO/β-CD/organic acid ternary complexes in different media (i.e. citrate buffer pH 3 and 6) was explored. The stoichiometric ratio between the drug and β-CD was 1:1 in all complexes formed. The solubility of HALO/β-CD binary complexes significantly increased in citrate buffer pH 3 compared with citrate buffer pH 6. For the ternary complexes, HALO/β-CD/tartaric acid and HALO/β-CD/lactic acid in citrate buffer pH 3 increased HALO solubility compared with HALO/β-CD/succinic acid due to their higher unionized species. The highest stability constant and complexation efficiency values in citrate buffer pH 3 were shown by the ternary complexes with lactic acid followed by tartaric acid and succinic acid, respectively. Results indicated that lactic acid provided the greatest binding strength and solubilization efficiency for the complex.

[1]  N. Shah,et al.  Supersolubilization and Amorphization of a Model Basic Drug, Haloperidol, by Interaction with Weak Acids , 2013, Pharmaceutical Research.

[2]  C. Tablet,et al.  The Determination of the Stoichiometry of Cyclodextrin Inclusion Complexes by Spectral Methods: Possibilities and Limitations , 2012 .

[3]  Jinming Gao,et al.  Nanonization strategies for poorly water-soluble drugs. , 2011, Drug discovery today.

[4]  J. Patil,et al.  INCLUSION COMPLEX SYSTEM; A NOVEL TECHNIQUE TO IMPROVE THE SOLUBILITY AND BIOAVAILABILITY OF POORLY SOLUBLE DRUGS: A REVIEW , 2010 .

[5]  V. Arán,et al.  Characterization, phase-solubility, and molecular modeling of inclusion complex of 5-nitroindazole derivative with cyclodextrins. , 2008, Bioorganic & medicinal chemistry.

[6]  Thorsteinn Loftsson,et al.  Cyclodextrins as pharmaceutical solubilizers. , 2007, Advanced drug delivery reviews.

[7]  Suzanne D Johanningsmeier,et al.  The chemistry and physiology of sour taste--a review. , 2007, Journal of food science.

[8]  Thorsteinn Loftsson,et al.  The complexation efficiency , 2007 .

[9]  Thorsteinn Loftsson,et al.  Evaluation of cyclodextrin solubilization of drugs. , 2005, International journal of pharmaceutics.

[10]  L. Kang,et al.  SMGA gels for the skin permeation of haloperidol. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[11]  G. Dive,et al.  The effect of cyclodextrins on the aqueous solubility of a new MMP inhibitor: phase solubility, 1 H-NMR spectroscopy and molecular modeling studies, preparation and stability study of nebulizable solutions. , 2005, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[12]  Hassan Almoazen,et al.  Investigation of Solubility and Dissolution of a Free Base and Two Different Salt Forms as a Function of pH , 2005, Pharmaceutical Research.

[13]  J. Samu,et al.  Uncommon Interactions of Aliphatic Dicarboxylic Acids with Cyclodextrins , 2005 .

[14]  L. Szente,et al.  Cyclodextrins as food ingredients , 2004 .

[15]  J. Pandit,et al.  Effect of cyclodextrins on the complexation and transdermal delivery of bupranolol through rat skin. , 2004, International journal of pharmaceutics.

[16]  U. Bondesson,et al.  Pharmacokinetics of haloperidol in psychotic patients , 2004, Psychopharmacology.

[17]  Michael J Akers,et al.  Excipient-drug interactions in parenteral formulations. , 2002, Journal of pharmaceutical sciences.

[18]  Chong-K. Kim,et al.  Microemulsion formulation of clonixic acid: solubility enhancement and pain reduction , 2002, The Journal of pharmacy and pharmacology.

[19]  É. Fenyvesi,et al.  Interaction of Hydroxy Acids with β-Cyclodextrin , 1999 .

[20]  O. Olesen,et al.  Simplified high-performance liquid chromatographic method for determination of risperidone and 9-hydroxyrisperidone in serum from patients comedicated with other psychotropic drugs. , 1997, Journal of chromatography. B, Biomedical sciences and applications.

[21]  D O Thompson,et al.  Cyclodextrins--enabling excipients: their present and future use in pharmaceuticals. , 1997, Critical reviews in therapeutic drug carrier systems.

[22]  M. Brewster,et al.  Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. , 1996, Journal of pharmaceutical sciences.

[23]  J. Zung,et al.  ALCOHOL SIZE AS A FACTOR IN THE TERNARY COMPLEXES FORMED WITH PYRENE AND BETA -CYCLODEXTRIN , 1991 .

[24]  Jos H. Beijnen,et al.  Cyclodextrins in the Pharmaceutical Field , 1991 .

[25]  K. Uekama,et al.  New Perspectives in Cyclodextrin Pharmaceutical Applications , 1990 .

[26]  D Wouessidjewe,et al.  High-field nuclear magnetic resonance techniques for the investigation of a beta-cyclodextrin:indomethacin inclusion complex. , 1990, Journal of pharmaceutical sciences.

[27]  D. Greene,et al.  High Pressure Liquid Chromatographic Determination of Haloperidol Stability , 1983 .

[28]  T. Higuchi,et al.  Phase solubility techniques , 1965 .

[29]  P. Demoen.  Properties and analysis of haloperidol and its dosage forms. , 1961, Journal of pharmaceutical sciences.